New lung cancer screening initiative looks to increase access to care“Key Takeaways – The initiative targets low-income, uninsured, and minority populations to reduce lung cancer disparities through bilingual support and no-cost screenings. Over 700 eligible...
Roche’s Alecensa receives NICE recommendation to treat ALK-positive lung cancer“Just under 100 non-small cell lung cancer patients in England will be eligible for the drug” FDA Presses Clinical Hold Button For BioNTech’s Partner Late-Stage Trial Of...
Obesity and survival in advanced non-small cell lung cancer patients treated with chemotherapy, immunotherapy, or chemoimmunotherapy: a multicenter cohort study“Obesity may be associated with an increased overall survival among male patients treated with chemotherapy,...
Quality Improvements in Lung Cancer Surgery and Tumor Pathology May Extend Survival Postsurgery““Over the past 15 years, a quality improvement initiative in the heart of the Mississippi Delta has made stepped progress to change the status quo for lung cancer outcomes...
Expectations concerning cancer treatment: perspectives of medical oncologists and patients on advanced, unresectable lung carcinoma“Introduction. This study seeks to compare expectations regarding systemic cancer treatment for advanced lung cancer from the...
Taletrectinib shows high response rates and safety in ROS1+ lung cancer patients“The ROS1 tyrosine kinase inhibitor (TKI) taletrectinib demonstrated high overall and intracranial responses, and a favorable safety profile with low incidence of neurologic adverse events...
More News and Updates